Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Myopathy

In brief

Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of chronic transcranial direct current stimulation sessions - associated with aerobic exercises - in the patients with systemic autoimmune myopathies.

Key facts

Study ID

NCT04678635

Run by

University of Sao Paulo

People needed

40

Starts

2020-12-12

Expected to finish

2024-12-04

Last updated by the study team

2024-12-09

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Classification criteria - EULAR/ACR 2017
• Classification critera - Connors et al.

You may not qualify if…

• Neoplasia
• Using heart pacemarker
• Using visceral metalic clips
• Infections (HIV, HTLV-1, Hepatitis, etc)
• Pregnance
• Previous historical of convulsions or epilepsies

Where it is running

• Samuel K Shinjo — São Paulo, São Paulo, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.